化学
孕烷X受体
核受体
兴奋剂
可药性
调节器
天然产物
肝再生
生物甾体
药理学
酰胺
生物化学
结构-活动关系
立体化学
芳香烃受体
癌症研究
受体
选择性
肝移植
异羟肟酸
部分激动剂
肝X受体
生物合成
移植
铅化合物
肝癌
再生(生物学)
甲酰胺
小分子
作者
Xuan Li,Lei Zheng,Xiaowen Jiang,Hai‐Guo Su,Chuoying Mai,Jinyi Li,Yujie Ni,Yonglin He,Wanyu Zheng,Qingqing Yu,Guofang Bi,Hui Ouyang,Shuang Hu,Chenghua Wu,Dan Li,Fengting Liang,Wenhong Zhou,Xiao Yang,Shicheng Fan,Jianhong Fang
标识
DOI:10.1021/acs.jmedchem.6c01983
摘要
Partial hepatectomy (PHx) and liver transplantation are the most effective interventions for end-stage liver diseases, yet druggable targets that promote donor or remnant liver regeneration are critically lacking. Pregnane X receptor (PXR), a key regulator of liver regeneration, is a promising therapeutic target. Previously, we identified the natural product Schisandrol B (SolB) as a PXR agonist to promote liver regeneration. To further improve its PXR activity and selectivity, the present study performed structural simplification of SolB and identified BZZ-034, a ring-opened analogue with an isobutyl amide side chain, as a novel PXR agonist. BZZ-034 exhibited higher PXR binding affinity and stronger transcriptional efficacy than SolB, along with greater selectivity against related nuclear receptors. In vivo, BZZ-034 significantly promoted hepatomegaly and accelerated liver regeneration after PHx in mice. These findings identify BZZ-034 as a promising lead compound and demonstrate that structural simplification is an effective strategy for optimizing complex natural products.
科研通智能强力驱动
Strongly Powered by AbleSci AI